InsidersTradesSigma
Track the Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) stock price and the full directors' dealings record of the company, a listed equity based in Canada. Shares trade on the CA market, under the authority of SEDI. Market capitalisation: €28.5m. The latest transaction was disclosed on 19 August 2026 (00 - Opening Balance-Initial SEDI Report). Among the most active insiders: Aharon, Gilad. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Thiogenesis Therapeutics, Corp. 是一家生物技术公司，专注于开发严重疾病的创新疗法。该公司前身为 Rozdil Capital Corporation，在 XTSE 上市。